파킨슨병에서 보이는 위장관기능장애

키워드

참고문헌 (54)

1. Makaroff L, "Gastrointestinal disorders in Parkinson's disease: prevalence and health outcomes in a US claims database", J Parkinsons Dis, 1, pp.65~74 (2011)
2. Pfeiffer RF, "Gastrointestinal dysfunction in Parkinson’s disease", Parkinsonism Relat Disord, 17, pp.10~15 (2011)
3. Cloud LJ, "Gastrointestinal features of Parkinson’s disease", Curr Neurol Neurosci Rep, 11, pp.379~384 (2011)
4. Cersosimo MG, "Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms", J Neurol, 260, pp.1332~1338 (2013)
5. Sung HY, "The frequency and severity of gastrointestinal symptoms in patients with early Parkinson's disease", J Mov Disord, 7, pp.7~12 (2014)
6. Abbott RA, "Diet, body size and micronutrient status in Parkinson’s disease", Eur J Clin Nutr, 46, pp.879~884 (1992)
7. Durrieu G, "Parkinson’s disease and weight loss: a study with anthropometric and nutritional assessment", Clin Auton Res, 2, pp.153~157 (1992)
8. Bachmann CG, "Body weight in patients with Parkinson's disease", Mov Disord, 21, pp.1824~1830 (2006)
9. Eadie MJ, "Alimentary disorder in parkinsonism", Australas Ann Med, 14, pp.13~22 (1965)
10. Edwards LL, "Gastrointestinal symptoms in Parkinson’s disease", Mov Disord, 6, pp.151~156 (1991)
11. Tumilasci OR, "Quantitative study of salivary secretion in Parkinson’s disease", Mov Disord, 21, pp.660~667 (2006)
12. Nóbrega AC, "Is drooling secondary to a swallowing disorder in patients with Parkinson’s disease?", Parkinsonism Relat Disord, 14, pp.243~245 (2008)
13. Arbouw ME, "Glycopyrrolate for sialorrhea in Parkinson disease: a randomized, double-blind, crossover trial", Neurology, 74, pp.1203~1207 (2010)
14. Ondo WG, "A double-blind placebo-controlled trial of botulinum toxin B for sialorrhea in Parkinson’s disease", Neurology, 62, pp.37~40 (2004)
15. Lagalla G, "Botulinum toxin type A for drooling in Parkinson’s disease: a double-blind, randomized, placebo-controlled study", Mov Disord, 21, pp.704~707 (2006)
16. Clarke CE, "Referral criteria for speech and language therapy assessment of dysphagia caused by idiopathic Parkinson’s disease", Acta Neurol Scand, 97, pp.27~35 (1998)
17. Leopold NA, "Prepharyngeal dysphagia in Parkinson’s disease", Dysphagia, 11, pp.14~22 (1996)
18. Bushmann M, "Swallowing abnormalities and their response to treatment in Parkinson’s disease", Neurology, 39, pp.1309~1314 (1989)
19. Leopold NA, "Pharyngo-esophageal dysphagia in Parkinson’s disease", Dysphagia, 12, pp.11~18 (1997)
20. Fuh JL, "Swallowing difficulty in Parkinson’s disease", Clin Neurol Neurosurg, 99, pp.106~112 (1997)
21. Potulska A, "Swallowing disorders in Parkinson’s disease", Parkinsonism Relat Disord, 9, pp.349~353 (2003)
22. Bird MR, "Asymptomatic swallowing disorders in elderly patients with Parkinson’s disease: a description of findings on clinical examination and videofluoroscopy in sixteen patients", Age Aging, 23, pp.251~254 (1994)
23. Thomas M, "Dysphagia, a reversible cause not to be forgotten", Postgrad Med J, 71, pp.94~95 (1995)
24. Sung HY, "The prevalence and patterns of pharyngoesophageal dysmotility in patients with early stage Parkinson's disease", Mov Disord, 25, pp.2361~2368 (2010)
25. McCallum SL, "The National Dysphagia Diet: implementation at a regional rehabilitation center and hospital system", J Am Diet Assoc, 103, pp.381~384 (2003)
26. Born LJ, "Cricopharyngeal dysfunction in Parkinson’s disease: role in dysphagia and response to myotomy", Mov Disord, 11, pp.53~58 (1996)
27. Truong DD, "Botulinum toxin: clinical use", Parkinsonism Relat Disord, 12, pp.331~355 (2006)
28. Edwards LL, "Gastrointestinal symptoms in Parkinson’s disease", Mov Disord, 6, pp.151~156 (1991)
29. Hardoff R, "Gastric emptying time and gastric motility in patients with Parkinson's disease", Mov Disord, 16, pp.1041~1047 (2001)
30. Lertxundi U, "Domperidone in Parkinson's disease: a perilous arrhythmogenic or the gold standard?", Curr Drug Saf, 8, pp.63~68 (2013)
31. Gabrielli M, "Prevalence of small intestinal bacterial overgrowth in Parkinson's disease", Mov Disord, 26, pp.889~892 (2011)
32. Fasano A, "The role of small intestinal bacterial overgrowth in Parkinson's disease", Mov Disord, 28, pp.1241~1249 (2013)
33. Siddiqui MF, "Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey", Parkinsonism Relat Disord, 8, pp.277~284 (2002)
34. Kaye J, "Excess burden of constipation in Parkinson’s disease: a pilot study", Mov Disord, 21, pp.1270~1273 (2006)
35. Stocchi F, "Anorectal function in multiple system atrophy and Parkinson’s disease", Mov Disord, 15, pp.71~76 (2000)
36. Jost WH, "Constipation in Parkinson’s disease", Klin Wochenschr, 69, pp.906~909 (1991)
37. Sakakibara R, "Colonic transit time and rectoanal videomanometry in Parkinson’s disease", J Neurol Neurosurg Psychiatry, 74, pp.268~272 (2003)
38. Edwards LL, "Characterization of swallowing and defecation in Parkinson’s disease", Am J Gastroenterol, 89, pp.15~25 (1994)
39. Kim JS, "Anorectal dysfunctions in Parkinson's disease", J Neurol Sci, 310, pp.144~151 (2011)
40. 성혜영, "Anorectal Manometric Dysfunctions in Newly Diagnosed, Early-Stage Parkinson’s Disease", Journal of Clinical Neurology, 8(3), pp.184~189 (2012), 대한신경과학회
41. Mathers SE, "Constipation and paradoxical puborectalis contraction in anismus and Parkinson’s disease: a dystonic phenomenon?", J Neurol Neurosurg Psychiatry, 51, pp.1503~1507 (1988)
42. Mathers SE, "Anal sphincter dysfunction in Parkinson’s disease", Arch Neurol, 46, pp.1061~1064 (1989)
43. Ashraf W, "Constipation in Parkinson’s disease: objective assessment and response to psyllium", Mov Disord, 12, pp.946~951 (1997)
44. Zangaglia R, "Macrogol for the treatment of constipation in Parkinson’s disease. A randomized placebo-controlled study", Mov Disord, 22, pp.1239~1244 (2007)
45. Camilleri M, "A placebo-controlled trial of prucalopride for severe chronic constipation", N Engl J Med, 358, pp.2344~2354 (2008)
46. Albanese A, "Severe constipation in Parkinson’s disease relieved by botulinum toxin", Mov Disord, 12, pp.764~766 (1997)
47. Ueki A, "Life style risks of Parkinson’s disease: association between decreased water intake and constipation", J Neurol, 251, pp.vii18~vii23 (2004)
48. Kaye J, "Excess burden of constipation in Parkinson’s disease: a pilot study", Mov Disord, 21, pp.1270~1273 (2006)
49. Ashraf W, "Constipation in Parkinson’s disease: objective assessment and response to psyllium", Mov Disord, 12, pp.946~951 (1997)
50. Siddiqui MF, "Autonomic dysfunction in Parkinson’s disease: a comprehensive symptom survey", Parkinsonism Relat Disord, 8, pp.277~284 (2002)
51. Abbott RD, "Frequency of bowel movements and the future risk of Parkinson’s disease", Neurology, 57, pp.456~462 (2001)
52. Derkinderen P, "Parkinson disease: the enteric nervous system spills its guts", Neurology, 77, pp.1761~1767 (2011)
53. Wakabayashi K, "Parkinson’s disease: the presence of Lewy bodies in Auerbach’s and Meissner’s plexuses", Acta Neuropathol, 76, pp.217~221 (1988)
54. Visanji NP, "Alimentary, my dear Watson? The challenges of enteric α-synuclein as a Parkinson's disease biomarker", Mov Disord, 29, pp.444~450 (2014)

관련 논문AI추천